Skip to Content

Label Changes for:

Proquin XR (ciprofloxacin hydrochloride) Extended-Release Tablets

October 2008

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- October 2008


The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary. Read about the new physician labeling format.

Summary View


Sections Modified


  • What if I receive a sample of Proquin XR from my healthcare provider? (new subsection)

Label approved 10/17/2008 is not available on this site.